-
Mashup Score: 1
The MOVe-NOW study will assess the investigational oral antiviral using a different formulation than what is currently approved under an emergency use authorization.
Source: www.drugtopics.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 0
Researchers addressed vaccine effectiveness for individuals with direct household contacts that reported influenza.
Source: www.drugtopics.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 1FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV - 2 month(s) ago
Abrysvo is the only RSV vaccine approved for use in this age group.
Source: www.drugtopics.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 6Chronic Hand Eczema Studies Show Condition is Common, Burdensome - 3 month(s) ago
LEO Pharma presented data from 2 of the largest multinational real-world studies on the prevalence, severity and treatment of chronic hand eczema at the European Society of Contact Dermatitis congress.
Source: www.drugtopics.comCategories: General Medicine News, Allergy-ImmunologyTweet
-
Mashup Score: 0
“While seasonal variation exists, it is expected that seniors will continue to benefit from flu vaccines that are stronger than the traditional standard-dose vaccines,” wrote investigators.
Source: www.drugtopics.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 36CVS PBM to Pay $45 Million in Rebates to State of Illinois - 5 month(s) ago
CVS Caremark and the State of Illinois settled a lawsuit due to the company’s failure to pay contracted rebates.
Source: www.drugtopics.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 36CVS PBM to Pay $45 Million in Rebates to State of Illinois - 5 month(s) ago
CVS Caremark and the State of Illinois settled a lawsuit due to the company’s failure to pay contracted rebates.
Source: www.drugtopics.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0
Researchers aimed to evaluate the efficacy of the OpenAI technology and offer guidance into its future implementation within health care services.
Source: www.drugtopics.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0
After 24 weeks of participation in an AI-driven lifestyle coaching program, 78% of all participants achieved a clinically meaningful SBP reduction of 5 mm Hg or greater.
Source: www.drugtopics.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 14Slideshow: The 5 Types of Asthma and Their Common Triggers - 7 month(s) ago
While many people may be unaware of the different types of asthma, there are 5 ways individuals can experience the condition, with common triggers that heighten symptoms.
Source: www.drugtopics.comCategories: General Medicine News, Allergy-ImmunologyTweet
“The trial will use a different formulation of molnupiravir that includes 2 smaller 400-mg tablets per dose instead of the currently available 4 200-mg capsules per dose.” https://t.co/rtPsJuDnOl